Oppenheimer & Co’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $331K | Buy |
4,390
+1
| +0% | +$71 | ﹤0.01% | 1348 |
|
|
2025
Q4 | $271K | Buy |
4,389
+292
| +7% | +$17.2K | ﹤0.01% | 1309 |
|
|
2025
Q3 | $241K | Sell |
4,097
-2,973
| -42% | -$173K | ﹤0.01% | 1475 |
|
|
2025
Q2 | $412K | Sell |
7,070
-6,457
| -48% | -$365K | 0.01% | 1215 |
|
|
2025
Q1 | $672K | Sell |
13,527
-13,358
| -50% | -$683K | 0.01% | 970 |
|
|
2024
Q4 | $1.2M | Buy |
26,885
+20,175
| +301% | +$958K | 0.02% | 715 |
|
|
2024
Q3 | $322K | Buy |
6,710
+174
| +3% | +$8.39K | ﹤0.01% | 1196 |
|
|
2024
Q2 | $333K | Sell |
6,536
-36
| -0.5% | -$1.97K | 0.01% | 1152 |
|
|
2024
Q1 | $357K | Buy |
6,572
+275
| +4% | +$14.3K | 0.01% | 1114 |
|
|
2023
Q4 | $355K | Sell |
6,297
-10,355
| -62% | -$585K | 0.01% | 1082 |
|
|
2023
Q3 | $1.03M | Buy |
16,652
+2,936
| +21% | +$186K | 0.02% | 666 |
|
|
2023
Q2 | $810K | Sell |
13,716
-4,290
| -24% | -$273K | 0.02% | 783 |
|
|
2023
Q1 | $1.33M | Buy |
18,006
+8,661
| +93% | +$668K | 0.03% | 581 |
|
|
2022
Q4 | $682K | Sell |
9,345
-7,909
| -46% | -$625K | 0.02% | 821 |
|
|
2022
Q3 | $1.44M | Buy |
17,254
+3,257
| +23% | +$280K | 0.03% | 530 |
|
|
2022
Q2 | $1.11M | Sell |
13,997
-17,204
| -55% | -$1.67M | 0.02% | 650 |
|
|
2022
Q1 | $3.25M | Sell |
31,201
-54,521
| -64% | -$4.52M | 0.06% | 374 |
|
|
2021
Q4 | $6.45M | Buy |
85,722
+35,873
| +72% | +$2.51M | 0.11% | 210 |
|
|
2021
Q3 | $3.23M | Buy |
49,849
+5,713
| +13% | +$349K | 0.06% | 362 |
|
|
2021
Q2 | $2.67M | Buy |
44,136
+20,011
| +83% | +$1.18M | 0.05% | 421 |
|
|
2021
Q1 | $1.3M | Buy |
24,125
+13,832
| +134% | +$752K | 0.03% | 613 |
|
|
2020
Q4 | $496K | Buy |
+10,293
| New | +$455K | 0.01% | 889 |
|
|
2020
Q1 | – | Sell |
-10,063
| Closed | -$482K | – | 1286 |
|
|
2019
Q4 | $482K | Buy |
10,063
+1,253
| +14% | +$60.5K | 0.01% | 848 |
|
|
2019
Q3 | $439K | Sell |
8,810
-2,433
| -22% | -$124K | 0.01% | 832 |
|
|
2019
Q2 | $601K | Sell |
11,243
-5,457
| -33% | -$285K | 0.02% | 745 |
|
|
2019
Q1 | $881K | Sell |
16,700
-9,806
| -37% | -$511K | 0.02% | 624 |
|
|
2018
Q4 | $1.25M | Sell |
26,506
-20,674
| -44% | -$1.08M | 0.04% | 462 |
|
|
2018
Q3 | $2.72M | Buy |
47,180
+7,840
| +20% | +$434K | 0.07% | 312 |
|
|
2018
Q2 | $2.14M | Buy |
39,340
+3,088
| +9% | +$153K | 0.06% | 371 |
|
|
2018
Q1 | $1.71M | Buy |
+36,252
| New | +$1.82M | 0.04% | 434 |
|
Other funds holding NTR
VCM
Oppenheimer & Co's NTR Position: Q1 2026 in Review
Oppenheimer & Co increased its Nutrien (NTR) stake by 0.02% in Q1 2026, buying an estimated $71 and bringing the position to 4,390 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #1348.
Oppenheimer & Co first reported a position in NTR in Q1 2018 and has held it in 30 quarters since. The position peaked at $6.45M in Q4 2021. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.
- Oppenheimer & Co held 4,390 shares of Nutrien worth $331K as of Q1 2026.
- Oppenheimer & Co bought 1 Nutrien share in Q1 2026, an estimated $71.
- Nutrien made up ﹤0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1348 holding.
- Oppenheimer & Co first reported a position in Nutrien in Q1 2018 and has held it in 30 quarters since.
- Oppenheimer & Co's Nutrien position peaked at $6.45M in Q4 2021.
- 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.
Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.